PRACTECAL-PKPD Sub Study

NCT04081077 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Multi-drug Resistant Tuberculosis
Extensively Drug-Resistant Tuberculosis
Pulmonary Tuberculosis

Interventions

DRUG: Bedaquiline
DRUG: Pretomanid
DRUG: Moxifloxacin
DRUG: Linezolid
DRUG: Clofazimine

Sponsor

Medecins Sans Frontieres, Netherlands

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]